• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
Classification Nameimmunohistochemistry assay, antibody, epidermal growth factor receptor
Generic Nameimmunohistochemistry assay, antibody, epidermal growth factor receptor
Regulation Number864.1860
PMA NumberP030044
Supplement NumberS001
Date Received11/17/2005
Decision Date02/01/2006
Product Code
NQF[ Registered Establishments with NQF ]
Advisory Committee Pathology
Supplement Typereal-time process
Supplement Reason labeling change - indications/instructions/shelf life/tradename
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for additional labeling changes include a clarification in the definition of positive staining for individual tumor cells, inclusion of limitation about cetuximab response rate for negative/ positive patients and performance indices for patients who had <1% positive tumor cells for egfr.